Pressure BioSciences receives $1.5M contract for UltraShear CBD

Pressure BioSciences and CBD Supply announced the execution and launch of a manufacturing and distribution agreement. Under the terms of the Agreement, PBIO will supply CBD Supply MD with the Company’s UltraShear optimized nanoemulsions of CBD in a CBD Topical Spray, formulated for ideal effectiveness and optimal potency, addressing consumer’s diverse CBD objectives. The Agreement is expected to generate over $1.5M in revenue for PBIO during 2023, including nearly $250,000 in the second quarter. The Agreement defines four phases of product development and commercialization for a custom-formulated topical spray of hemp-derived, UltraShear nanoemulsified CBD designed for extremely rapid absorption and effectiveness and for efficient high potency delivery of the CBD active material in each dose. All ingredients used in the manufacture of the Company’s nano-CBD are sourced from naturally-occurring, plant-based origins. Phase I of the Agreement is underway and provides for an initial shipment of 850 vials of UltraShear-nanoemulsified CBD to CBD Supply MD by mid-April 2023.